Tissue plasminogen activator cells

Protein G. This vitamin K-dependent glycoproteia serine protease zymogen is produced ia the Hver. It is an anticoagulant with species specificity (19—21). Proteia C is activated to Proteia by thrombomodulin, a proteia that resides on the surface of endothefial cells, plus thrombin ia the presence of calcium. In its active form, Proteia selectively iaactivates, by proteolytic degradation. Factors V, Va, VIII, and Villa. In this reaction the efficiency of Proteia is enhanced by complex formation with free Proteia S. la additioa, Proteia activates tissue plasminogen activator, which... 

Tissue plasminogen activator 530 amino acids, glycosylated E. coli Yeast Animal cells Acute mycocardial infarct Pulmonary embolism Approved for sale Animal cell culture most effective way of producing active enzyme... 

Plasminogen activator inhibitors have been shown to be present in a large variety of different cells and tissues. These inhibitors are thought to play an important role in regulating tissue fibrinolysis. One of these inhibitors has been purified from cultured bovine aortic epithelial cells. This inhibitor has been shown to be a serine protease inhibitor and inhibits the function of two proteolytic enzymes urokinase and tissue plasminogen activator, both of which cleave and activate plasminogen. The mechanism by which this inhibitor functions is very similar to that described above with a-l-PI. Thus, the inhibitor forms a binary complex with the proteolytic enzyme and thereby inhibits its activity. Again in a situation comparable to that with a-l-PI, it was found that when the purified bovine aortic epithelial inhibitor was exposed to Al-chlorosuccinimide,... 

The antithrombotic factors produced by endothelial cells are thrombomodulin (TM) and protein S (PS), components of the vitamin K-dependent protein C (PC) anticoagulant pathway, inhibiting F-Va-F-Villa (E15) tissue plasminogen activator (tPA), responsible for fibrinolysis (N2, LI8) and the lipoprotein-associated coagulation inhibitor (LACI), which inhibits F-VIIa-TF complex and F-Xa (B51). 

N2. Nakashima, Y., Sueishi, K., and Tanaka, K Thrombin enhances production and release of tissue plasminogen activator from bovine venous endothelial cells. Fibrinolysis 2, 227-234 (1988). 

Mammalian cell suspension cultures are the preferred choice for large-scale recombinant protein production in stirred-tank bioreactors. The most widely used systems are Chinese hamster ovary (CHO) cells and the murine myeloma fines NSO and SP2/0. In half of the biological license approvals from 1996-2000, CHO cells were used for the production of monoclonal antibodies and other recombinant glycosylated proteins, including tPA (tissue plasminogen activator) and an IgGl fusion with the tumor necrosis factor (TNF) receptor, the latter marketed as Enbrel [7]. 

Datar, R.V. Cartwright, T., and Rosen, C.G. 1993. Process economics of animal cell and bacterial fermentations a case study analysis of tissue plasminogen activator. Bio/Technology 11, 340-357. 

Tissue paper products, 13 129-130 Tissue plasminogen activator (t-PA) bioseparation from mammalian cell culture, 3 821-826 peptide map, 3 841, 842 selling price, 3 817t Tissue reactions, to sutures, 24 218 Tissue-type plasminogen activator (t-PA) and hemostatic system, 4 89 human, use as thrombolytic agent,... 

Keratan sulfate (102-104), hen ovomucin (105), rat gastric mucins (106), porcine thyroglobulin (107) Recombinant tissue plasminogen activator expressed in mouse epithelial cells (108)... 

H12. Hajjar, K. A., The endothelial cell tissue plasminogen activator receptor. J. Biol. Chem. 266, 21962-21970 (1991). 

The mechanisms of the influence of the SNS on the induction of CD8+ Tregs are likely directed towards both the activation and function of these cells (fig. 2). Sympathetic neurons are a source of (i) norepinephrine that has strong immunoregulatory effects [35] including the proliferation of liver NKT cells necessary for the initiation of contact sensitivity reactions (ii) immunomodulatory NPY [38] that may promote the production of IFN-y necessary for the function of CD8+ suppressor T cells (see below), and (hi) tissue plasminogen activator (t-PA) [41] that converts plasminogen to plasmin that in turn is an activator of immunosuppressive TGF-(3 [42]. 

Fig. 2. Sympathetic neurons influence the development or activity of CD8+ suppressor cells. Sympathetic neurons are a source of neuropeptide Y (NPY), norepinehprine (NE) or tissue plasminogen activator (t-PA) that respectively, (i) activate IL-12, IFN-7 necessary for the activity of suppressor cells, (ii) NK cells required to generate CD8+ suppressor cells after the injection of antigen into the AC, (ill) the conversion of plasminogen to plasmin that activates immunosuppressive GF-p produced by the CD8+ suppressor cells.

Along with the production of insulin, many other medical uses have been achieved for recombinant DNA. This includes the production of erythropoetin, a hormone used to stimulate production of red blood cells in anemic people tissue plasminogen activator, an enzyme that dissolves blood clots in heart attack victims and antihemophilic human factor VIII, used to prevent and control bleeding for hemophiliacs. These three important genetically engineered proteins were all cloned in hamster cell cultures. 

Van Reis et al. [92] reported the scale-up of a HF system for the recovery of human tissue plasminogen activator (t-PA) produced by recombinant CHO cells from the 2.5-m to the 180-m scale. A robust and reproducible process was achieved by combining hnear scale-up principles, control of fluid dynamic parameters and experimentally defined limits of product retention, which meant maintaining channel length, wall shear rate and flux constant. 

ReFacto (Moroctocog-a, i.e. Genetics Institute B-domain-deleted rhFactor VIII produced in CHO cells) Recombinant tissue plasminogen activator-based products Haemophilia A 1999 (EU), 2000 (USA)... 

AC VIII, adenylyl cyclase type VIII BDNF, brain-derived neurotrophic factor CamKII, calcium-calmodulin kinase II GIRK2, G protein-activated inward rectifying potassium 2 MAOA, monoamine oxidase A n.d., not determined NCAM, neural cell adhesion molecule nNOS, neuronal nitric oxide synthase Petl, ETS domain transcription factor tPA, serine protease tissue-plasminogen activator (tPA). t/ > Increase/decrease in anxiety-related behavior. No effect. 

Secretion of tissue plasminogen activator by cultured endothelial cells increases within an hour after exposure to arterial levels of shear stress [11], while secretion of the related inhibitor (plasminogen inhibitor-1) by the same cells is unaffected by shear forces over the physiological range. 

S. L. Diamond, S.G. Eskin, L.V. Mclntire, Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells. Science 243(4897) (1989) 1483. 

While some parenteral injections, such as intravenous administration, provide rapid and predictable access to the circulation and tissues, therapeutic proteins are rapidly cleared from the system, and thus such administrations may result in very short durations of action. Regardless of route of administration, therapeutic proteins may exhibit limited distribution outside of endothelial cells lining blood vessels. This may be advantageous for thrombolytic agents, such as tissue plasminogen activator, which is used for rapid fibrinolytic actions at... 

Tenecteplase, human recombinant tissue plasminogen activator (tPA) produced in CHO cells... 

---